Bamlanivimab is indicated for:
Population group: only adults (18 years old or older)
Treatment of mild-to-moderate COVID-19 in patients aged ≥12 years who weigh ≥40 kg with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
Patient selection
High-risk defined as meeting at least 1 of these criteria:
BMI ≥35
Chronic kidney disease
Diabetes
Immunosuppressive disease
Receiving immunosuppressive treatment
Age ≥65 years
Age ≥55 years and have cardiovascular disease, hypertension, or COPD/chronic respiratory disease
For this indication, competent medicine agencies globally authorize below treatments (click for details):
Population group: only adolescents (12 years - 18 years old)
Treatment of mild-to-moderate COVID-19 in patients aged ≥12 years who weigh ≥40 kg with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progressing to severe COVID-19 and/or hospitalization.
Patient selection
High-risk defined as meeting at least 1 of these criteria:
Chronic kidney disease
Diabetes
Immunosuppressive disease
Receiving immunosuppressive treatment
Additional high-risk factors in patients aged 12-17 years:
BMI ≥85th percentile for their age and sex based on CDC growth charts
Sickle cell disease
Congenital or acquired heart disease
Neurodevelopmental disorders (eg, cerebral palsy)
Medical-related technological dependence (eg, tracheostomy, gastrostomy, positive-pressure ventilation [not related to COVID-19])
Asthma, reactive airway diease, or other chronic respiratory disease requiring daily medication for control
For this indication, competent medicine agencies globally authorize below treatments (click for details):
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
